Hap Trading, LLC Zynerba Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$1.83 - $3.02 $30,195 - $49,830	-16,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.88 - $4.3 $6,624 - $9,890	-2,300 Reduced 12.23%	16,500 $1,000
Q3 2021 Nov 10, 2021	BUY	$3.72 - $5.35 $69,936 - $100,580	18,800 New	18,800 $7,000
Q1 2021 May 14, 2021	SELL	$3.33 - $8.76 $89,910 - $236,520	-27,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.27 - $4.64 $88,290 - $125,279	27,000 New	27,000 $2,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.